---
tags:
  - pharm
---
- Class IIb recommendation
	- Might be *considered* for **primary prevention** of ASCVD among select adults 40-70 years of age who are at <u>higher</u> [[ASCVD Risk Calculator|ASCVD risk]] but <u>not at increased bleeding risk</u>